title: Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study.
abstract: The role of different cytokines and cells of immune system in the pathogenesis of chronic GVHD (cGVHD) is still controversial. Earlier studies, which were either retrospective or analysed one or a few factors, did not show unequivocal results. We prospectively evaluated cytokine levels and lymphocyte subsets in 30 patients who underwent Allo-SCT to investigate their possible correlation with cGVHD. Levels of IL-4, IL-6, IL-10, IFN-gamma, tumour necrosis factor-alpha (TNF-alpha) and its soluble receptors were assessed by ELISA in 30 patients at different times after SCT. Lymphocyte subsets were evaluated by flow cytometry in peripheral blood at the same times as cytokines. A multivariate analysis was performed using principal component analysis and multi-factor ANOVA (analysis of variance). Eighteen patients developed cGVHD at a median time of 6 months (range, 5-9) after SCT. In multivariate analysis, we observed a correlation between cGVHD and clusters of cytokines and lymphocyte subsets from the third to the sixth month after SCT. These clusters changed their composition over time, but they constantly included natural killer (NK) and CD152+ T cells as negative predictors of cGVHD. TNF-alpha prevailed among other cytokines before the onset of cGVHD. This prevalence could be related partly to the defect of immunoregulatory cells.
authors.affiliation: Stem Cell Transplantation Unit, Department of Haematology, University of Brescia, Piazzale Spedali Civili 1, Brescia, Italy. cristina_skert@yahoo.it
authors.forename: C
authors.initials: C
authors.lastname: Skert
authors.forename: D
authors.initials: D
authors.lastname: Damiani
authors.forename: A
authors.initials: A
authors.lastname: Michelutti
authors.forename: F
authors.initials: F
authors.lastname: Patriarca
authors.forename: M
authors.initials: M
authors.lastname: Arpinati
authors.forename: C
authors.initials: C
authors.lastname: Filì
authors.forename: P
authors.initials: P
authors.lastname: Lucchi
authors.forename: M
authors.initials: M
authors.lastname: Malagola
authors.forename: C
authors.initials: C
authors.lastname: Bergonzi
authors.forename: A
authors.initials: A
authors.lastname: Roccaro
authors.forename: A
authors.initials: A
authors.lastname: Peli
authors.forename: D
authors.initials: D
authors.lastname: Ricotta
authors.forename: L
authors.initials: L
authors.lastname: Caimi
authors.forename: R
authors.initials: R
authors.lastname: Fanin
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
authors.forename: D
authors.initials: D
authors.lastname: Russo
mesh_terms: D000328:Adult; D000368:Aged; D002908:Chronic Disease; D016207:Cytokines / Q000097:blood / Q000276:immunology*; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D011446:Prospective Studies; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*; D019172:Transplantation Conditioning / Q000379:methods; D055815:Young Adult
chemical_list: D016207:Cytokines